Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults, Aged 18 Years and Above
Clinical trial NCT01885117 · COMPLETED
Trial details
- NCT number
- NCT01885117
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2013-09-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.